Brief: Zhongzhi Pharmaceutical Posts FY Profit Attributable RMB138.5 Mln Vs RMB114.7 Mln
March 25 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
3737.HK :
* FY PROFIT ATTRIBUTABLE RMB138.5 MILLION VERSUS RMB114.7
MILLION
* FY REVENUE RMB1.60 BILLION VERSUS RMB1.34 BILLION
* PROPOSED SPECIAL INTERIM DIVIDEND HK1.45 CENTS PER SHARE
* PROPOSED INTERIM DIVIDEND HK3.70 CENTS PER SHARE
Source text for Eikon: ID:nHKSc8x0yF
Further company coverage: 3737.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all newsBrief: Zhongzhi Pharmaceutical Expects Over 70% Decrease In 2025 Net Profit
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share